Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hyun‐Gyung Goh
Observed names:
Hyun Gyung Goh,
Hyun-Gyung Goh,
Hyun-gyung Goh
Institutions:
The Catholic University of Korea Seoul St. Mary's Hospital,
Catholic University of Korea
Observed institutions:
The Catholic University of Korea Uijeongbu St. Mary's Hospital,
St. Paul's Hospital,
The Catholic University of Korea Seoul St. Mary's Hospital,
Catholic University of Korea
OpenAlex ID:
A5108615116
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
2010
·
Helen E. White
, Paul Matejtschuk
, et al.
·
Blood
·
171
Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay
2011
·
Hyun-Gyung Goh
, Min Lin
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
110
Allele frequencies of 15 STR loci using AmpF/STR Identifiler kit in a Korean population
2003
·
Yoo-Li Kim
, Ji-Yeon Hwang
, et al.
·
Forensic Science International
·
74
Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR
2006
·
Hyun-Gyung Goh
, Ji-Yeon Hwang
, et al.
·
Translational research
·
64
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy
2009
·
Hyun-Gyung Goh
, Yoo-Jin Kim
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
61
Comparison of allele specific oligonucleotide-polymerase chain reaction and direct sequencing for high throughput screening of ABL kinase domain mutations in chronic myeloid leukemia resistant to imatinib.
2006
·
Ho-Young Kang
, Ji-Yeon Hwang
, et al.
·
PubMed
·
60
Analysis of Bcr‐Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P‐loop and T315I mutation is disease phase dependent
2009
·
Soo‐Hyun Kim
, Dongho Kim
, et al.
·
Hematological Oncology
·
56
Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era
2010
·
Dong-Wook Kim
, Shripad D. Banavali
, et al.
·
Leukemia Research
·
50
Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy
2011
·
Dongho Kim
, Hyun-Gyung Goh
, et al.
·
International Journal of Hematology
·
31
Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation
2012
·
Dongho Kim
, Hyun Gyung Goh
, et al.
·
International Journal of Hematology
·
28
Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations
2009
·
Dongho Kim
, Dong-Wook Kim
, et al.
·
Leukemia Research
·
20
Efficacy of Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib (RE-NICE Multicenter Study)
2011
·
Hyun-Gyung Goh
, Saengsuree Jootar
, et al.
·
Blood
·
17
Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse
2004
·
Yoo-Jin Kim
, Dong-Wook Kim
, et al.
·
Transplantation and Cellular Therapy
·
13
PDF
Dynamic change of T315I BCR‐ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors
2009
·
Wan‐Seok Kim
, Dongho Kim
, et al.
·
Hematological Oncology
·
12
Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response4.5 (CMR4.5)
2011
·
Hyun-Gyung Goh
, Soo-Young Choi
, et al.
·
Blood
·
10
A Review of Mutation Analysis In the TOPS Trial of Standard Dose Versus High Dose IM In CML Suggests That Refinements to the ELN Recommendations for Mutation Screening May Be Appropriate
2010
·
Susan Branford
, Hyun-Gyung Goh
, et al.
·
Blood
·
9
Genotyping of Chimerical BCR-ABL1 RNA in Chronic Myeloid Leukemia by Integrated DNA Chip
2012
·
Jong-Hun Kang
, Hyun-Gyung Goh
, et al.
·
Journal of Molecular Diagnostics
·
4
PDF
Impact of Baseline BCR-ABL Transcript Levels on the Response to Imatinib In CP CML Patients
2010
·
Hyun-Gyung Goh
, Dongho Kim
, et al.
·
Blood
·
1
Mutation Analysis of BCR-ABL Tyrosine Kinase Domain In New Chronic Phase-Chronic Myeloid Leukemia Patients with Suboptimal Response or Treatment Failure From Imatinib Treatment.
2010
·
Dong-Wook Kim
, Dongho Kim
, et al.
·
Blood
·
1
Monitoring of Dynamics of BCR-ABL Transcripts Over Time Using Digital PCR Assay In CP CML Patients After Achieving Complete Molecular Remission
2010
·
Hyun-Gyung Goh
, Dongho Kim
, et al.
·
Blood
·
1
Correlation of Molecular Response At 18 Month with Survival Benefits As Response-Related Prognostic Factor
2011
·
Soo-Hyun Kim
, Dongho Kim
, et al.
·
Blood
Dynamics and Characteristics of BCR-ABL Multiple Mutations In Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia.
2010
·
Dong-Wook Kim
, Dongho Kim
, et al.
·
Blood
Outcome of Patients with Chronic Myeloid Leukemia Who Recieved an Intermittent Imatinib Therapy.
2007
·
Hyun-Gyung Goh
, Soo-Hyun Kim
, et al.
·
Blood
Clinical Characteristics and Outcome of 20 Imatinib Mesylate Resistant Patients with T315I BCR-ABL Mutation.
2007
·
Wan-Seok Kim
, Il-Young Kweon
, et al.
·
Blood
Show more works
View as search
Works count:
24
Citation count:
793
H-index:
13
I10-index:
15
Year
Topic
Type